Product Information
ETHYNODIOL-ETH ESTRA 1 MG-35 MCG is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.3819 per EA under NDC 00378730753. Its NADAC has been published 459 times since Nov 8, 2017.
FDA first approved this application on Jul 28, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378730753
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA204703FDA Approved
7/28/2016
TE Code
AB
On Market Since
9/19/2017
Price Statistics
The NADAC for ETHYNODIOL-ETH ESTRA 1 MG-35 MCG has been published 459 times since Nov 8, 2017, and over the history we have for it it has declined 39.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3819 per EA |
|---|---|
| All-time high | $0.6391 (Jan 10, 2018) |
| All-time low | $0.2253 (Nov 20, 2024) |
| 52-week high | $0.3819 |
| 52-week low | $0.3004 |
| Median price | $0.4040 |
| Average price | $0.4094 |
| Largest weekly change | +53.0% (Jun 19, 2024) |
| Weeks tracked | 459 |
| Tracking since | Nov 8, 2017 |
1W
N/A
1M
N/A
3M
+22.1%
6M
+12.9%
1Y
+10.7%
3Y
+11.6%
5Y
-10.9%
All
-39.9%
Last surveyed Aug 19, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ethynodiol diacetate and ethinyl estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ETHYNODIOL-ETH ESTRA 1 MG-35 MCG?
The current National Average Drug Acquisition Cost (NADAC) for ETHYNODIOL-ETH ESTRA 1 MG-35 MCG, manufactured by Mylan Pharmaceuticals Inc., is $0.3819 per EA (NDC 00378730753), effective Aug 19, 2026.
How has the price of ETHYNODIOL-ETH ESTRA 1 MG-35 MCG changed over time?
Over the history we have for it, the NADAC for ETHYNODIOL-ETH ESTRA 1 MG-35 MCG has declined 39.9%. It has been tracked across 459 weekly CMS publications since Nov 8, 2017.
What are the highest and lowest recorded NADAC prices for ETHYNODIOL-ETH ESTRA 1 MG-35 MCG?
Since Nov 8, 2017, the NADAC for ETHYNODIOL-ETH ESTRA 1 MG-35 MCG has ranged from a low of $0.2253 (Nov 20, 2024) to a high of $0.6391 (Jan 10, 2018), with a median of $0.4040 per EA.
Are there cheaper alternatives to ETHYNODIOL-ETH ESTRA 1 MG-35 MCG?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ETHYNODIOL-ETH ESTRA 1 MG-35 MCG in a comparable dosage form, but none are currently priced below it.
Who manufactures ETHYNODIOL-ETH ESTRA 1 MG-35 MCG?
ETHYNODIOL-ETH ESTRA 1 MG-35 MCG (NDC 00378730753) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.